Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161246
Status:
COMPLETED
Last Update Posted:
2024-03-22
First Post:
2023-11-30
Brief Title:
A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
Sponsor:
Galderma RD
Organization:
Galderma RD
Study Overview
Official Title:
An Open-label Randomized Split-face Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label single-center randomized split-face controlled study to assess the effect of comfort intervention on pain during treatment injection compared against non-comfort intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None